May 2, 2024 · Form 4 insider transaction
Murray Dallan sold 3,635 shares of Sarepta Therapeutics, Inc. at $140.00 per share, a transaction worth $508.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024.